Variant report

Variant	esv3414441
Chromosome Location	chr6:118227509-118229957
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:321)
CpG islands
(count:856)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:321 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:118228186-118228196	HepG2	liver:	n/a	n/a
2	ATF2	chr6:118228003-118228332	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr6:118228015-118228606	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr6:118229212-118230132	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL11A	chr6:118227602-118227933	GM12878	blood:	n/a	chr6:118227708-118227716 chr6:118227675-118227684
6	CCNT2	chr6:118228940-118229076	K562	blood:	n/a	n/a
7	CEBPB	chr6:118228044-118228291	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD1	chr6:118228478-118228536	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD1	chr6:118229235-118229834	H1-hESC	embryonic stem cell:	n/a	n/a
10	CHD1	chr6:118228003-118228230	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD2	chr6:118228033-118228426	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD2	chr6:118228799-118228935	HepG2	liver:	n/a	n/a
13	CREB1	chr6:118229200-118230061	H1-hESC	embryonic stem cell:	n/a	n/a
14	CREB1	chr6:118227880-118228494	H1-hESC	embryonic stem cell:	n/a	n/a
15	CREB1	chr6:118229115-118229908	H1-hESC	embryonic stem cell:	n/a	n/a
16	CREB1	chr6:118227949-118228483	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTBP2	chr6:118227970-118229940	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr6:118228178-118228380	SK-N-SH_RA	brain:	n/a	chr6:118228288-118228304
19	CTCF	chr6:118228200-118228350	GM12873	blood:	n/a	chr6:118228288-118228304
20	CTCF	chr6:118228180-118228330	GM12872	blood:	n/a	chr6:118228288-118228304
21	CTCF	chr6:118228240-118228390	HepG2	liver:	n/a	chr6:118228288-118228304
22	CTCF	chr6:118228160-118228310	BJ	skin:	n/a	chr6:118228288-118228304
23	CTCF	chr6:118228060-118228210	AG04450	lung:	n/a	n/a
24	CTCF	chr6:118228164-118228365	K562	blood:	n/a	chr6:118228288-118228304
25	CTCF	chr6:118228160-118228310	HEK293	kidney:	n/a	chr6:118228288-118228304
26	CTCF	chr6:118228477-118228488	GM19240	blood:	n/a	n/a
27	CTCF	chr6:118228180-118228330	GM12874	blood:	n/a	chr6:118228288-118228304
28	CTCF	chr6:118228147-118228493	HepG2	liver:	n/a	chr6:118228288-118228304
29	CTCF	chr6:118228120-118228270	AoAF	blood vessel:	n/a	n/a
30	CTCF	chr6:118228180-118228330	HCPEpiC	choroid plexus:	n/a	chr6:118228288-118228304
31	CTCF	chr6:118228160-118228310	HRPEpiC	eye:	n/a	chr6:118228288-118228304
32	CTCF	chr6:118228496-118228517	GM19240	blood:	n/a	n/a
33	CTCF	chr6:118228160-118228310	HMF	breast:	n/a	chr6:118228288-118228304
34	CTCF	chr6:118227900-118228050	HFF-Myc	foreskin:	n/a	n/a
35	CTCF	chr6:118228414-118228416	GM19239	blood:	n/a	n/a
36	CTCF	chr6:118228160-118228310	HBMEC	blood vessel:	n/a	chr6:118228288-118228304
37	CTCF	chr6:118228229-118228401	LNCaP	prostate:	n/a	chr6:118228288-118228304
38	CTCF	chr6:118228059-118228066	GM19238	blood:	n/a	n/a
39	CTCF	chr6:118228160-118228310	HL-60	blood:	n/a	chr6:118228288-118228304
40	CTCF	chr6:118228180-118228330	HCM	heart:	n/a	chr6:118228288-118228304
41	CTCF	chr6:118228182-118228351	MCF-7	breast:	n/a	chr6:118228288-118228304
42	CTCF	chr6:118228060-118228210	A549	lung:	n/a	n/a
43	CTCF	chr6:118228520-118228525	GM19240	blood:	n/a	n/a
44	CTCF	chr6:118228420-118228570	GM12864	blood:	n/a	n/a
45	CTCF	chr6:118228180-118228330	AG09309	skin:	n/a	chr6:118228288-118228304
46	CTCF	chr6:118228160-118228310	HPF	lung:	n/a	chr6:118228288-118228304
47	CTCF	chr6:118228200-118228350	HCM	heart:	n/a	chr6:118228288-118228304
48	CTCF	chr6:118228200-118228350	HFF-Myc	foreskin:	n/a	chr6:118228288-118228304
49	CTCF	chr6:118228154-118228417	Gliobla	brain:	n/a	chr6:118228288-118228304
50	CTCF	chr6:118228116-118228397	K562	blood:	n/a	chr6:118228288-118228304

(count:856 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:118228060-118228110	Caco-2	colon:	n/a
2	chr6:118228498-118228548	HRE	kidney:	n/a
3	chr6:118228060-118228110	Caco-2	colon:	n/a
4	chr6:118228498-118228548	HRE	kidney:	n/a
5	chr6:118228498-118228548	SAEC	small airway:	n/a
6	chr6:118227732-118227782	HCM	heart:	n/a
7	chr6:118228493-118228543	ovcar-3	ovarian:	n/a
8	chr6:118229732-118229782	RPTEC	kidney:	n/a
9	chr6:118229732-118229782	PFSK-1	brain:	n/a
10	chr6:118227732-118227782	AG09309	skin:	n/a
11	chr6:118228650-118228700	HEK293	kidney:	embryo
12	chr6:118228514-118228564	Hela-S3	cervix:	n/a
13	chr6:118228650-118228700	GM06990	blood:	n/a
14	chr6:118227732-118227782	Hela-S3	cervix:	n/a
15	chr6:118229732-118229782	GM12891	blood:	n/a
16	chr6:118227732-118227782	SK-N-SH	brain:	n/a
17	chr6:118228493-118228543	HEEpiC	esophagus:	n/a
18	chr6:118228382-118228432	U87	brain:	n/a
19	chr6:118228514-118228564	PANC-1	pancreas:	n/a
20	chr6:118228514-118228564	GM12891	blood:	n/a
21	chr6:118228060-118228110	PANC-1	pancreas:	n/a
22	chr6:118228498-118228548	AG10803	skin:	n/a
23	chr6:118228078-118228128	NHDF-neo	bronchial:	n/a
24	chr6:118229641-118229691	GM19239	blood:	n/a
25	chr6:118228493-118228543	BE2_C	brain:	n/a
26	chr6:118228382-118228432	GM12878	blood:	n/a
27	chr6:118227732-118227782	HNPCEpiC	eye:	n/a
28	chr6:118228078-118228128	T-47D	breast:	n/a
29	chr6:118228871-118228921	HCT-116	colon:	n/a
30	chr6:118228869-118228919	LNCaP	prostate:	n/a
31	chr6:118228869-118228919	PFSK-1	brain:	n/a
32	chr6:118228498-118228548	HepG2	liver:	n/a
33	chr6:118228493-118228543	SKMC	muscle:	n/a
34	chr6:118228060-118228110	NHBE	bronchial:	n/a
35	chr6:118229641-118229691	ProgFib	skin:	n/a
36	chr6:118228514-118228564	HepG2	liver:	n/a
37	chr6:118228498-118228548	IMR90	lung:	fetal
38	chr6:118228869-118228919	NHDF-neo	bronchial:	n/a
39	chr6:118228869-118228919	HL-60	blood:	n/a
40	chr6:118228060-118228110	Jurkat	blood:	n/a
41	chr6:118228498-118228548	HPAEpiC	pulmonary alveolar:	n/a
42	chr6:118228508-118228558	HNPCEpiC	eye:	n/a
43	chr6:118228493-118228543	Hepatocyte	liver:	n/a
44	chr6:118229732-118229782	NB4	blood:	n/a
45	chr6:118228650-118228700	Hepatocyte	liver:	n/a
46	chr6:118228871-118228921	SKMC	muscle:	n/a
47	chr6:118228060-118228110	ovcar-3	ovarian:	n/a
48	chr6:118229306-118229356	RPTEC	kidney:	n/a
49	chr6:118227732-118227782	BE2_C	brain:	n/a
50	chr6:118229732-118229782	HCM	heart:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:118161401..118162100-chr6:118227994..118228639,2	MCF-7	breast:

No data

Variant related genes	Relation type
SLC35F1	TF binding region
SLC35F1	CpG island

Extended variants
information (count: 77 )
Associated
traits (count: 109 )

Variant overlapped rSNPs/rCNVs (count:77 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs201761967	chr6:118227552-118227553	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs112243759	chr6:118227582-118227583	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs2788997	chr6:118227589-118227590	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs569215247	chr6:118227652-118227653	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs559479290	chr6:118227699-118227700	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs533003671	chr6:118227703-118227704	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs62432035	chr6:118227725-118227726	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs151154465	chr6:118227759-118227760	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs534391793	chr6:118227778-118227779	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs548558066	chr6:118227788-118227789	Active TSS Enhancers Bivalent/Poised TSS Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs570016388	chr6:118227866-118227867	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs555597207	chr6:118227875-118227876	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs559558282	chr6:118227942-118227943	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs77336277	chr6:118227961-118227962	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs574054060	chr6:118228000-118228001	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs140080143	chr6:118228042-118228043	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs556557279	chr6:118228067-118228068	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs578063395	chr6:118228077-118228078	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs73768108	chr6:118228102-118228103	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs554093055	chr6:118228122-118228123	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs572162529	chr6:118228178-118228179	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs6931715	chr6:118228250-118228251	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs552192124	chr6:118228300-118228301	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs570594655	chr6:118228301-118228302	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs150383793	chr6:118228317-118228318	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs371819812	chr6:118228341-118228342	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs367934713	chr6:118228354-118228355	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs191654783	chr6:118228359-118228360	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs6931916	chr6:118228365-118228366	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs184930796	chr6:118228369-118228370	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs71012374	chr6:118228372-118228373	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs531394780	chr6:118228447-118228448	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs543101669	chr6:118228501-118228502	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs2788996	chr6:118228527-118228528	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs531956926	chr6:118228552-118228553	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs115448160	chr6:118228567-118228568	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs189872101	chr6:118228715-118228716	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs567121242	chr6:118228780-118228781	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs527903427	chr6:118228797-118228798	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs549509606	chr6:118228798-118228799	Active TSS Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs567664894	chr6:118228834-118228835	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs553451687	chr6:118228915-118228916	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs375649871	chr6:118228961-118228962	Bivalent/Poised TSS Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs556691774	chr6:118229006-118229007	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs200756021	chr6:118229057-118229058	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs539000565	chr6:118229069-118229070	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs553803625	chr6:118229081-118229082	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs572257047	chr6:118229091-118229092	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs542466073	chr6:118229096-118229097	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs111915578	chr6:118229100-118229101	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:109)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Burkitt''s lymphoma	18698080	CNVD
Ovarian cancer	21720365	CNVD
Prostate cancer	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Cancer	20164920	CNVD
Breast cancer	21364760	CNVD
Chordoma	21602918	CNVD
Kartagener syndrome	16639409	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17133270	CNVD
Follicular lymphoma	18703704	CNVD
Mental retardation	17621639	CNVD
Hypoplastic	20877625	CNVD
Hypotonia	20877625	CNVD
Mental retardation	20877625	CNVD
Microcephaly	20877625	CNVD
brachycephaly	20877625	CNVD
epicanthic folds	20877625	CNVD
micrognathia	20877625	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Salivary gland tumor	18059337	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Metastatic melanoma	18483359	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD

Chromatin state (count:385 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:118226400-118227600	Enhancers	Cortex derived primary cultured neurospheres	brain
2	chr6:118226800-118228000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr6:118227200-118227600	Active TSS	Brain Anterior Caudate	brain
4	chr6:118227400-118227600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr6:118227400-118227600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
6	chr6:118227400-118227600	Active TSS	Brain Hippocampus Middle	brain
7	chr6:118227400-118227600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
8	chr6:118227400-118227800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr6:118227400-118227800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr6:118227400-118227800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
11	chr6:118227400-118228200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr6:118227400-118230200	Active TSS	Brain Angular Gyrus	brain
13	chr6:118227400-118230400	Active TSS	Brain Inferior Temporal Lobe	brain
14	chr6:118227600-118227800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
15	chr6:118227600-118227800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr6:118227600-118227800	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
17	chr6:118227600-118227800	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
18	chr6:118227600-118227800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
19	chr6:118227600-118227800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
20	chr6:118227600-118227800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
21	chr6:118227600-118227800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr6:118227600-118227800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr6:118227600-118227800	Flanking Active TSS	Brain Cingulate Gyrus	brain
24	chr6:118227600-118227800	Active TSS	Brain Substantia Nigra	brain
25	chr6:118227600-118227800	Bivalent Enhancer	Duodenum Mucosa	Duodenum
26	chr6:118227600-118227800	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
27	chr6:118227600-118227800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
28	chr6:118227600-118227800	Bivalent Enhancer	Fetal Intestine Large	intestine
29	chr6:118227600-118227800	Bivalent Enhancer	Fetal Intestine Small	intestine
30	chr6:118227600-118227800	Bivalent Enhancer	Fetal Lung	lung
31	chr6:118227600-118227800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
32	chr6:118227600-118227800	Bivalent Enhancer	HepG2	liver
33	chr6:118227600-118227800	Bivalent Enhancer	Osteobl	bone
34	chr6:118227600-118228000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr6:118227600-118228000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
36	chr6:118227600-118228000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
37	chr6:118227600-118228000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
38	chr6:118227600-118228000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
39	chr6:118227600-118228000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
40	chr6:118227600-118228000	Flanking Active TSS	Brain Anterior Caudate	brain
41	chr6:118227600-118228000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
42	chr6:118227600-118228000	Enhancers	Colonic Mucosa	Colon
43	chr6:118227600-118228200	Active TSS	Fetal Brain Male	brain
44	chr6:118227600-118228200	Bivalent Enhancer	Fetal Heart	heart
45	chr6:118227600-118228800	Active TSS	ES-I3 Cell Line	embryonic stem cell
46	chr6:118227600-118228800	Active TSS	Stomach Smooth Muscle	stomach
47	chr6:118227600-118229000	Bivalent Enhancer	Liver	Liver
48	chr6:118227600-118229000	Active TSS	Brain Germinal Matrix	brain
49	chr6:118227600-118229400	Active TSS	Fetal Brain Female	brain
50	chr6:118227600-118229600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links